Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study
Version of Record online: 24 SEP 2007
Alimentary Pharmacology & Therapeutics
Volume 26, Issue 10, pages 1387–1398, November 2007
How to Cite
RAHME, E., NEDJAR, H., BIZZI, A. and MORIN, S. (2007), Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study. Alimentary Pharmacology & Therapeutics, 26: 1387–1398. doi: 10.1111/j.1365-2036.2007.03523.x
- Issue online: 24 SEP 2007
- Version of Record online: 24 SEP 2007
- Publication data Submitted 4 July 2007 First decision 8 August 2007 Resubmitted 10 September 2007 Accepted 18 September 2007
- 4Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 2218–24., , , et al.Direct Link:
- 5Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002; 46: 328–46.
- 14Survival analysis with PHREG: using MI and MIANALYZE to accommodate missing data. In: Proceedings of the 10th Annual Western Users of SAS Software Regional Users Group Conference. Cary, NC: SAS Institute Inc., 2002: 102–7., .
- 15Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2007; 369: 465–73., , , et al.
- 17COX-2 specific inhibition with MK-0966 25 or 50 mg Q.D. over 4 weeks does not increase fecal blood loss: a controlled study with placebo and ibuprofen 800 mg T.I.D. Am J Gastroenterol 1998; 93: 1671., , , et al.
- 25Methods in Observational Epidemiology, 2nd edn. New York: Oxford University Press, Inc., 1996., , , et al.